Stockscreener 앱 받기
1.18
0.00%
0.00
Bionano Genomics Inc 주식(BNGO)의 최신 뉴스
Alex Reid Hastie Net Worth (2026) - GuruFocus
Bionano Genomics (BNGO) investor discloses 9.9% position via warrants - Stock Titan
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD) - The Globe and Mail
Maxim Group Maintains Bionano Genomics(BNGO.US) With Buy Rating, Maintains Target Price $4 - moomoo.com
Bionano Genomics Inc (BNGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bionano Reports Second Quarter 2026 Results and Provides a Business Update - moomoo.com
Bionano Genomics earnings beat by $0.13, revenue topped estimates - Investing.com Nigeria
Bionano Genomics, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:BNGO) 2026-08-11 - Seeking Alpha
Bionano Genomics Q2 2026 Earnings Call Transcript - MarketBeat
Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: - GuruFocus
Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: Record Flow Cell Sales and ... - Yahoo! Finance Canada
Bionano Genomics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Bionano Genomics Q2 Results: Revenue rises 21% to $8.2 million - scanx.trade
Bionano Genomics Q3 Results: Sales guidance ranges $8.200M-$8.600M - scanx.trade
BNGO Looks 21.6% Undervalued on GF Value™ Despite Unprofitabilit - GuruFocus
BIONANO GENOMICS ($BNGO) Releases Q2 2026 Earnings - Quiver Quantitative
How Could Bionano Genomics (NASDAQ:BNGO) Influence Penny Stocks Sentiment? - Kalkine Media
Bionano Genomics, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
BNGO: Record Q2 revenue and margin driven by clinical adoption, with growth limited by supply constraints - TradingView
Is Bionano Genomics Inc (BNGO) Undervalued After Q2 Earnings? EPS: -$7.4M, Revenue: $8.2M, GF Score: 64/100 - GuruFocus
Transcript : Bionano Genomics, Inc., Q2 2026 Earnings Call, Aug 10, 2026 - marketscreener.com
Earnings call transcript: Bionano Genomics tops Q2 revenue view, shares edge up - Investing.com
Bionano Genomics raises FY26 sales guidance range - scanx.trade
Q2 2026 Bionano Genomics Inc Earnings Call Transcript - GuruFocus
Bionano Genomics Q2 revenue rises on increased clinical adoption - TradingView
BNGO: Q2 2026 revenue rose 21% but liquidity concerns threaten ongoing operations - TradingView
Bionano Reports Q2 2026 Revenue of $8.2M, Gross Margin 53% - TradingView
Bionano Genomics, Inc. Q2 2026: Revenue $8.17M, EPS $(0.64) — 10-Q Summary - TradingView
Bionano Genomics (NASDAQ: BNGO) grows revenue amid going concern warning - Stock Titan
BRIEF-Bionano Genomics Q2 Revenue USD 8.2 Million - TradingView
Bionano Genomics, Inc. Provides Revenue Guidance for the Third Quarter and Full Year of 2026 - marketscreener.com
Bionano Genomics (NASDAQ:BNGO): What Could Today’s Update Reveal About Adoption And Liquidity Ahead Of The Update? - Kalkine Media
BNGO: Q2 2026 revenue rose 21% to $8.2M, with margin gains and raised full-year guidance - TradingView
Bionano Genomics (BNGO) Earnings Date and Reports 2026 - MarketBeat
Bionano Genomics | 8-K: Current report - moomoo.com
BNGO Looks 22.1% Undervalued on GF Value™ - GuruFocus
Bionano Genomics, Inc. expected to post a loss of 68 cents a shareEarnings Preview - TradingView
Bionano Genomics Inc (BNGO) Stock News Today - TradingKey
BioNano Genomics Inc (0A4K) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
BioNano Genomics Inc (0A4K) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
BioNano Genomics Inc (0A4K) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
BioNano Genomics Inc (0A4K) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
BioNano Genomics Inc (0A4K) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
BioNano Genomics Inc (0A4K) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Earnings To Watch: Bionano Genomics Inc (BNGO) Q2 2026 -- GF Val - GuruFocus
Earnings To Watch: Bionano Genomics Inc (BNGO) Q2 2026 -- GF Value Sees 27% Upside - Yahoo Finance
BNGO Q2'26 Earnings: EPS estimate is (0.67) USD - TradingView
Bionano Genomics (BNGO) grants 5,000 options to officer - Stock Titan
Bionano Genomics (NASDAQ: BNGO) awards 15,000 options to its general counsel - Stock Titan
Bionano Genomics (NASDAQ: BNGO) awards CSO 54,000 options vesting from 2027 - Stock Titan
Bionano Genomics (BNGO) awards 15,000 stock options to its COO - Stock Titan
Bionano Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Hastie Alex Reid - moomoo.com
Bionano Genomics, Inc. (BNGO) CSO lists 54,000-share stock option position - stocktitan.net
Bionano Genomics (NASDAQ: BNGO) GC lists 15,000 stock option shares - Stock Titan
Bionano Genomics (BNGO) COO discloses 15,000-share stock option at $1.12 - Stock Titan
Earnings Preview: BNGO to Report Financial Results Post-market on August 10 - Moomoo
BNGO Q2'26 Earnings: revenue estimate is 7.55M USD - TradingView
Bionano Genomics, Inc. Revenue Breakdown – NASDAQ:BNGO - TradingView
Bionano Genomics | 3: Initial statement of beneficial ownership of securities- Hastie Alex Reid - moomoo.com
Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026 - The Manila Times
Bionano Genomics Announces Date for Second Quarter 2026 Financial Results Conference Call and Webcast - Quiver Quantitative
Bionano's Q2 Results Webcast Will Stay Online for at Least 30 Days - Stock Titan
Bionano Genomics Inc (BNGO) Cash Flow - TradingKey
Bionano Genomics Inc (BNGO) Balance Sheet - TradingKey
BNGO|Bionano Genomics Inc|Price:1.110| - TradingKey
Bionano Genomics Inc (BNGO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bionano Genomics Inc (BNGO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BNGO|Bionano Genomics Inc|Price:1.095|Chg%:+0.025 - TradingKey
Bionano Genomics Inc (BNGO) Earnings Date & Reports & Earnings News - TradingKey
Bionano Genomics Inc (BNGO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BNGO|Bionano Genomics Inc|Price:1.075|Chg%:-0.005 - TradingKey
Bionano Genomics Inc (BNGO) Income Statement - TradingKey
Bionano Genomics, Inc. Revenue Breakdown – BMV:BNGO - TradingView
2.90%
1.18%
자본화:
|
볼륨(24시간):